As a leader in the OTC pain category, GSK Consumer Healthcare is not aware of any scientific evidence that directly links worse outcomes in patients suffering from COVID-19 infection with the use of ibuprofen or other anti-inflammatories. Learn more here.
The following information is intended for use only by residents of Canada. Countries outside of Canada may have regulatory requirements or medical practices that are different than those in Canada and may require reference to different or additional information. Therefore, this information may not be appropriate outside of Canada.